(Circulation. 1996;94:2055-2056.)
© 1996 American Heart Association, Inc.
Articles |
Key Words: anticoagulants thrombosis prosthesis valves Editorials
| Introduction |
|---|
The study reported in this issue of Circulation by Acar et al and the AREVA Group6 is well designed, well conducted, and focused on lower-risk patients. It addresses the optimal target level for anticoagulation. They compared a target INR of 2.0 to 3.0 with 3.0 to 4.5 in a randomized trial after a single mechanical prosthetic valve replacement with either of two bileaflet mechanical prostheses (St Jude valve in 81% and Omnicarbon valve in 19% of the 433 patients) placed
This article has been cited by other articles:
![]() |
A. Kulik, F. D. Rubens, P. S. Wells, C. Kearon, T. G. Mesana, J. van Berkom, and B.-K. Lam Early Postoperative Anticoagulation After Mechanical Valve Replacement: A Systematic Review Ann. Thorac. Surg., February 1, 2006; 81(2): 770 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Laffort, R. Roudaut, X. Roques, S. Lafitte, C. Deville, J. Bonnet, and E. Baudet Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the st. jude medical prosthesis: A clinical and transesophageal echocardiographic study J. Am. Coll. Cardiol., March 1, 2000; 35(3): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |